Sign in

CIK 0001561921

  • Non-accelerated filer
  • Smaller reporting company

TELA Bio, Inc.

Sign in to watch
Ticker
TELA
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
455320061
Phone
+1 484-320-2930
Business address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA, 19355
Open-market buys, last 90 days
$167,238
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$167,238. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Capper Joseph H +$167K Director 2 filings
Date Insider Transaction Shares Price Value Owned after
2020-04-03 EW HEALTHCARE PARTNERS FUND 2, L.P. 10% owner Purchase +9,634 $8.01 $77K 1,193,865
2020-04-02 EW HEALTHCARE PARTNERS FUND 2, L.P. 10% owner Purchase +15,000 $8.01 $120K 1,184,231
2020-04-01 EW HEALTHCARE PARTNERS FUND 2, L.P. 10% owner Purchase +15,000 $7.47 $112K 1,169,231
2020-01-27 Murphy Peter C. Chief Commercial Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2019-12-17 RTW INVESTMENTS, LP 10% owner Sale −36,000 $11.32 $408K 1,139,358
2019-12-13 RTW INVESTMENTS, LP 10% owner Purchase +23,900 $11.60 $277K 1,175,358
2019-11-13 KOBLISH ANTONY Chief Executive Officer Conversion +7,277 139,860
2019-11-13 KOBLISH ANTONY Chief Executive Officer Conversion +14,225 154,085
2019-11-13 KOBLISH ANTONY Chief Executive Officer Conversion · Series A Preferred Stock −179,685 0
2019-11-13 KOBLISH ANTONY Chief Executive Officer Conversion · Series B Preferred Stock −351,271 0
2019-11-13 KOBLISH ANTONY Chief Executive Officer Conversion · Warrant (right to buy) −10,775 0
2019-11-13 KOBLISH ANTONY Chief Executive Officer Conversion · Warrant (right to buy) −10,775 10,775
2019-11-13 Ellis Ronald J. Jr. Director Conversion +580,357 774,056
2019-11-13 Ellis Ronald J. Jr. Director Conversion · Series B Preferred Stock −14,329,052 0
2019-11-13 Quaker BioVentures II LP 10% owner Conversion +345,489 1,234,153
2019-11-13 Quaker BioVentures II LP 10% owner Conversion +516,947 1,751,100
2019-11-13 Quaker BioVentures II LP 10% owner Conversion · Series A Preferred Stock −8,530,145 0
2019-11-13 Quaker BioVentures II LP 10% owner Conversion · Series B Preferred Stock −12,763,434 0
2019-11-13 Quaker BioVentures II LP 10% owner Conversion · Warrant (right to buy) −446,813 0
2019-11-13 Quaker BioVentures II LP 10% owner Conversion · Warrant (right to buy) −446,813 446,813

Page 25 of 29 · 565 trades